Expression of DOG1, CD117 and PDGFRA in Gastrointestinal Stromal Tumors and Correlations with Clinicopathology |
Sun, Xiu-Wei
(Department of Gastroenterology, the Third Affiliated Hospital of Harbin Medical University)
Feng, Zhan-Jun (Department of Gastroenterology, the Third Affiliated Hospital of Harbin Medical University) Huang, Peng (Department of Gastroenterology, the Third Affiliated Hospital of Harbin Medical University) Hao, Wang (Department of Gastroenterology, the Third Affiliated Hospital of Harbin Medical University) Sui, Xing-Ling (Department of Gastroenterology, the Third Affiliated Hospital of Harbin Medical University) |
1 | Borquez Ma P, Neveu CR (2008). Gastrointestinal stromal tumors. An update. Rev Med Chil, 136, 921-9. |
2 | Caputo A, Caci E, Ferrera L, et al (2008). TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science, 322, 590-4. DOI |
3 | Carles A, Millon R, Cromer A, et al (2006). Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display. Oncogene, 25, 1821-31. DOI |
4 | Corless CL, Heinrich MC (2008). Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol, 3, 557-86. DOI |
5 | Dow N, Giblen G, Sobin LH, et al (2006). Gastrointestinal stromal tumors, differential Diagnosis. Semin Diagn Pathol, 23, 111-9. DOI |
6 | Espinosa I, Lee CH, Kim MK, et al (2008). A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol, 32, 210-8. DOI ScienceOn |
7 | Heinrich MC, Corless CL, Duensing A, et al (2003). PDGFRA activating mutations in gastrointestinal stromal tumors. Science, 299, 708-10. DOI ScienceOn |
8 | Hornick JL, Fletcher CD (2002). Immunohistochemical staining for KIT(CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol, 117, 188-93. DOI ScienceOn |
9 | Joensuu H (2008). Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol, 39, 1411-9. DOI |
10 | Kang YN, Jung HR, Hwang I (2010). Clinicopathological and immunohistochemical features of gastrointestinal stromal tumors. Cancer Res Treat, 42, 135-43. DOI |
11 | Lopes LF, West RB, Bacchi LM, et al (2010). DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST), Comparison between 2 different antibodies. Appl Immunohistochem Mol Morphol, 18, 333-7. DOI |
12 | Medeiros F, Corless CL, Duensing A, et al (2004). KIT-negative gastrointestinal stromal tumors, proof of concept and therapeutic implications. Am J Surg Pathol, 28, 889-94. DOI ScienceOn |
13 | Miettinen M, Lasota J (2006). Gastrointestial stromal tumors, review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med, 130, 1466-78. |
14 | Miettinen M, Sobin LH, Lasota J (2005). Gastrointestinal stromal tumors of the stomach, a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol, 29, 52-68. DOI ScienceOn |
15 | Miettinen M, Wang ZF, Lasota J (2009). DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors, a study of 1840 cases. Am J Surg Pathol, 33, 1401-8. DOI ScienceOn |
16 | Miwa S, Nakajima T, Murai Y, et al (2008). Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs). J Gastroenterol, 43, 531-7. DOI ScienceOn |
17 | Novelli M, Rossi S, Rodriguez-Justo M, et al (2010). DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology, 57, 259-70. DOI |
18 | Pauls K, Merkelbach-Bruse S, Thal D, et al (2005). PDGFRalphaand c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features. Histopathology, 46, 166-75. DOI ScienceOn |
19 | Peterson MR, Piao Z, Weidner N, et al (2006). Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors, Immunohistochemical and mutational analyses. Appl Immunohistochem Mol Morphol, 14, 390-6. DOI |
20 | Rossi CR, Mocellin S, Mencarelli R, et al (2003). Gastrointestinal stromal tumors, from a surgical to a molecular approach. Int J Cancer, 107, 171-6. DOI |
21 | Stamatakos M, Douzinas E, Stefanaki C, et al (2009). Gastrointestinal stromal tumor. World J Surg Oncol, 7, 61. DOI |
22 | Rossi G, Valli R, Bertolini F, et al (2005). PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of gastrointestinal tract. Histopathology, 46, 522-31. DOI |
23 | West RB, Corless CL, Chen X, et al (2004). The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors orrespective of KIT or PDGFRA mutations status. Am J Pathol, 165, 107-13. DOI |
24 | Yang YD, Cho H, Koo JY, et al (2008). TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature, 455, 1210-5. DOI |
![]() |